Key Highlights
- USD 2.80 was the non-GAAP EPS posted by Intuitive Surgical (NASDAQ:ISRG) for the second quarter, including USD 0.08 from tariff refunds, on revenue of USD 2.89 billion, up 19 percent. It is expected to report October 20, 2026, after the close.
- USD 7.26 was the core operating income per share posted by Chubb (NYSE:CB) for the second quarter, up 18.2 percent, with a combined ratio of 83.8 percent. Results are due after the close on October 20, 2026, with a call the next morning.
- USD 17.2 billion was second quarter revenue at IBM (NYSE:IBM), up 1 percent, with software up 5 percent and infrastructure down 7 percent, according to the company letter. Its third quarter webcast is October 21, 2026, at 5:00 p.m. ET.
- USD 1.38 to 1.46 is the third quarter adjusted EPS guidance from Abbott Laboratories (NYSE:ABT), which reports before the open on October 21, 2026, with a 9:00 a.m. ET call. Published consensus near USD 1.43 sits inside that range.
Intuitive Surgical (NASDAQ:ISRG)
Intuitive Surgical is expected by published calendars to report on October 20, 2026, after the close, though its own date notice could not be retrieved. The second quarter release showed revenue of USD 2.89 billion, up from USD 2.44 billion, worldwide procedure growth of about 16 percent, da Vinci growth of about 15 percent and Ion growth of about 36 percent. The installed base reached 11,710 systems, up 12 percent. Non-GAAP EPS of USD 2.80 included USD 0.08 from refunds of tariffs paid in prior periods, so about USD 2.72 excluding that item, simple arithmetic on two disclosed numbers. Guidance calls for da Vinci procedure growth of 13.5 to 15.5 percent and a non-GAAP gross margin of 68.0 to 69.0 percent, including a tariff impact of about 1.0 percent of revenue. Published consensus for the third quarter is about USD 2.63 to 2.70 EPS on USD 2.9 to 3.0 billion of revenue, and published data shows beats in the first two quarters of 2026. The risk is that tariffs beyond current expectations, which the company flags as material, or slower procedure growth could pressure margins.
Chubb (NYSE:CB)
Chubb confirmed that it will release third quarter results after the market closes on October 20, 2026, with the conference call on Wednesday, October 21, 2026, at 8:30 a.m. ET. In the second quarter it earned USD 7.26 of core operating income per share against a published consensus of USD 6.77, and net income was USD 7.30 per share. Net premiums written were USD 14.7 billion, up 3.6 percent, with property and casualty up 3.0 percent and life insurance up 7.5 percent. A combined ratio of 83.8 percent means the property and casualty business paid out and spent about 84 cents per dollar of premium, leaving the remainder before investment income. Published calendars put third quarter consensus at about USD 6.53 to 6.79, below the second quarter result, and revenue estimates conflict so none is cited. Analyst consensus is Hold, with Morgan Stanley at a USD 350 target and Keefe, Bruyette and Woods at USD 387, according to published data. The main risks are catastrophe losses during the third quarter and softer commercial property pricing.
IBM (NYSE:IBM)
IBM will hold its third quarter webcast on Wednesday, October 21, 2026, at 5:00 p.m. ET, with the press release posted on its investor site beforehand. The company letter for the second quarter reported revenue of USD 17.2 billion, up 1 percent, with software up 5 percent, consulting flat and infrastructure down 7 percent. Operating EPS was USD 2.93, up 5 percent, while GAAP diluted EPS fell 2 percent to USD 2.27. Free cash flow was USD 4.8 billion for the year to date. IBM had expected infrastructure to decline by a low single-digit percentage for the year, and the second quarter came in worse than that. Published calendars show third quarter consensus of about USD 2.89 EPS on USD 17.0 billion of revenue, slightly under the second quarter operating EPS. The mechanism to watch is mix: software carries the margin, while infrastructure depends on hardware cycles that can swing results. The share reaction to the last report was not verified here. The risk is that consulting stays flat and the infrastructure decline deepens.
Abbott Laboratories (NYSE:ABT)
Abbott will announce third quarter results on Wednesday, October 21, 2026, before the market opens, with a conference call at 9:00 a.m. ET, according to its September 30 notice. Second quarter sales were USD 12.59 billion, up 13.0 percent reported but 4.8 percent on a comparable basis, because the Exact Sciences acquisition lifted the reported figure. Adjusted EPS was USD 1.31, up 4.0 percent. Medical Devices grew 8.4 percent and Diabetes Care 9.0 percent, while Diagnostics rose 2.9 percent and Nutrition fell 3.6 percent. Management raised 2026 adjusted EPS guidance to USD 5.45 to 5.60 from USD 5.38 to 5.58 and reaffirmed comparable sales growth of 6.5 to 7.5 percent. Because the second quarter grew 4.8 percent, the full-year range implies faster growth in the second half, simple arithmetic on the guidance. Published consensus is about USD 1.43 EPS on USD 13.1 billion of revenue. The risks are weak rapid and molecular diagnostics sales, down 8.0 percent, and nutrition volumes.
Where Things Stand
It depends: Intuitive Surgical (NASDAQ:ISRG) beat in each of the last two quarters, but part of its second quarter EPS came from tariff refunds that will not repeat. Chubb (NYSE:CB) reports first on October 20, 2026, after the close, facing consensus below its last result. Abbott Laboratories (NYSE:ABT) reports before the open on October 21 and must show acceleration to support its full-year range. IBM (NYSE:IBM) closes the group at 5:00 p.m. ET that day, with infrastructure the swing factor. Only Abbott reports before the open, so it is the exception to an after-the-close theme. This is a preview, not investment advice.






Please wait processing your request...